Three-year recurrence of Dupuytren’s contracture after needle fasciotomy and collagenase injection: a two-centre randomized controlled trial

Abstract

Collagenase injection and needle fasciotomy have similar short-term outcomes in the treatment of Dupuytren’s contracture. The purpose of this study was to compare the recurrence rate of these two procedures 3 years after index treatment of primary disease. We enrolled 93 patients (96 rays) from a previous two-centre randomized controlled trial. The rays that had been retreated or showed an increase in the total passive extension deficit of 30° or more compared with 3 months after treatment were regarded as recurrences. Seventeen of 40 needle fasciectomies and 12 of 36 of collagenase injections had recurred. This difference was not statistically significant. We conclude that collagenase injection and needle fasciotomy have similar 3-year recurrence rates in the treatment of Dupuytren’s contracture.

Level of evidence: I

Keywords

Dupuytren’s disease needle fasciotomy collagenase injection randomized controlled trial recurrence rate

Get full access to this article

View all access options for this article.

References

Bryan

Ghorbal

. The long-term results of closed palmar fasciotomy in the management of Dupuytren's contracture. J Hand Surg Br. 1988, 13: 254–6.

Cheng

Hung

Tse

. Needle aponeurotomy for Dupuytren's contracture. J Orthop Surg (Hong Kong). 2008, 16: 88–90.

Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg Br. 2003, 28: 427–31.

Hansen

Werlinrud

Larsen

Ipsen

Lauritsen

. Difference in success treating proximal interphalangeal and metacarpophalangeal joints with collagenase: results of 208 treatments. Plast Reconstr Surg Glob Open. 2017, 5: e1275.

Hurst

Badalamente

Hentz

, et al. Injectable collagenase clostridium histolyticum for Dupuytren’s contracture. N Engl J Med. 2009, 361: 968–79.

Peimer

Blazar

Coleman

, et al. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data. J Hand Surg Am. 2013, 38: 12–22.

Rowley

Couch

Chesney

Norris

. Assessment of percutaneous fasciotomy in the management of Dupuytren’s contracture. J Hand Surg Br. 1984, 9: 163–4.

Scherman

Jenmalm

Dahlin

. One-year results of needle fasciotomy and collagenase injection in treatment of Dupuytren’s contracture: a two-centre prospective randomized clinical trial. J Hand Surg Eur. 2016, 41: 577–82.

Skov ST, Bisgaard T, Sondergaard P, Lange J. Injectable collagenase versus percutaneous needle fasciotomy for dupuytren contracture in proximal interphalangeal joints: A randomized controlled trial. J Hand Surg Am. 2017, 42: 321–8 e3.

10.

Stromberg

Ibsen-Sorensen

Friden

. Comparison of treatment outcome after collagenase and needle fasciotomy for Dupuytren contracture: a randomized, single-blinded, clinical trial with a 1-year follow-up. J Hand Surg Am. 2016, 41: 873–80.

11.

Tang

. Re: Levels of experience of surgeons in clinical studies. J Hand Surg Eur. 2009, 34: 137–8.

12.

Tang

Giddins

. Why and how to report surgeons' levels of expertise. J Hand Surg Eur. 2016, 41: 365–6.

13.

van Rijssen AL, Werker PM. Percutaneous needle fasciotomy in dupuytren's disease. J Hand Surg Br. 2006, 31: 498–501.

14.

van Rijssen

Gerbrandy

Ter Linden

Klip

Werker

. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren’s disease: a 6-week follow-up study. J Hand Surg Am. 2006, 31: 717–25.